Active Filter(s):
Details:
BNL-101 is a drug-device combination comprised of doxorubicin as the active drug component together with the company's Bionaut™ microscale robots.
Lead Product(s): Doxorubicin Hydrochloride
Therapeutic Area: Oncology Product Name: BNL-101
Highest Development Status: N/A Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 23, 2021